Understanding Sclerotic Changes: Causes, Symptoms & Conditions

Sclerosis = pathological hardening of tissue from excessive fibrous connective tissue deposition (collagen) ± calcification. It is a response to chronic injury, inflammation, or metabolic stress.

Organ-Specific Sclerotic Conditions

1. Arteriosclerosis / Atherosclerosis: Intimal thickening, lipid-laden foam cells, fibrosis, calcification → luminal narrowing. Coronary, cerebral, peripheral.
2. Bone sclerosis: Osteosclerosis (↑ density) – osteoarthritis (subchondral), Paget's, osteopetrosis, metastatic (prostate, breast).
3. Pulmonary fibrosis: Usual interstitial pneumonia (UIP/IPF), hypersensitivity pneumonitis, CTD-ILD → honeycombing, traction bronchiectasis.
4. Liver cirrhosis: Bridging fibrosis → regenerative nodules. Etiologies: alcohol, HCV, NAFLD/NASH, HBV, autoimmune.
5. Renal sclerosis: Nephrosclerosis (hypertensive, diabetic) – arteriolar hyalinosis, glomerular sclerosis, tubular atrophy.
6. Multiple sclerosis (MS): CNS demyelination + gliotic scars (sclerotic plaques) – autoimmune.
7. ALS: Motor neuron degeneration → lateral corticospinal tract sclerosis + anterior horn loss.
8. Sclerosing cholangitis: PSC (IBD-associated), IgG4-related – bile duct fibrosis/strictures.
9. Systemic sclerosis (scleroderma): Skin + visceral fibrosis (lung, GI, heart, kidney).

Therapeutic Sclerosis (Sclerotherapy)

• Varicose veins (polidocanol, STS).
• Esophageal varices (endoscopic).
• Hemorrhoids, cysts, lymphangiomas.

Implications

• Organ dysfunction (stiffness → compliance ↓).
• Ischemia (vascular narrowing).
• Mechanical obstruction (strictures).
• Malignant transformation risk (cirrhosis → HCC, IPF → lung CA).

Early intervention on underlying driver slows progression.